Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

赫赛莱 - NMPA Drug Approval Details

Approvals/NMPA/Trastuzumab Emtansine for Injection

Approved

生物制品

Trastuzumab Emtansine for Injection

Roche Pharma (Schweiz) AG🇨🇳 National Medical Products Administration

Approval Date: Jan 21, 2020
Approval ID: 7ucitsfzMW0
Company: Roche Pharma (Schweiz) AG
Type: 生物制品

Approval Details

Approval Id: 7ucitsfzMW0
Approval Number: S20200003
Generic Name: 注射用恩美曲妥珠单抗
Generic Name En: Trastuzumab Emtansine for Injection
Trade Name: 赫赛莱
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 100mg/瓶
Reg Date: 2020-01-21
Expired Date: 2025-01-20
Company Name: Roche Pharma (Schweiz) AG
Company Address: Grenzacherstrasse 124, 4058 Basel, Switzerland
Production Company Name: F. Hoffmann-La Roche Ltd
Production Company Address: Wurmisweg CH-4303 Kaiseraugst Switzerland
Company Detail Path: /organization/roche-pharma-schweiz-ag
Production Company Detail Path: /organization/f-hoffmann-la-roche-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 21, 2020

Approval ID

7ucitsfzMW0

Type

生物制品

Back to NMPA Approvals